In this Section |
219724 Peer-driven intervention increases rates of screening for AIDS clinical trials among persons living with HIV/AIDS from racial/ethnic minority backgroundsWednesday, November 10, 2010
: 12:45 PM - 1:00 PM
Background: Persons living with HIV/AIDS (PLHA) from racial/ethnic minority backgrounds are under-represented in AIDS clinical trials (ACTs). PLHA gain access to ACTs through a screening process, but minorities face serious multi-level barriers to ACTs and are screened at low rates. We examined the efficacy of a peer-driven intervention (PDI) to increase rates of screening among minority PLHA.
Methods: A randomized controlled trial design examined the efficacy of PDI compared to a time/attention-matched control. PDI consisted of structured small group and individual sessions (6 hours) and the opportunity to educate three peers. Participants were recruited using respondent-driven sampling (N=342). Many (43.9%) participants were female, most (88.3%) were aged 41 years or older, and 91.5% were racial/ethnic minorities (64.9% African-American, 26.6% Latino). Most (93.3%) completed all intervention sessions and 61.4% recruited/educated peers. Baseline and 16 weeks post-baseline interviews were computer-assisted (94.4% follow-up rate). A logistic mixed model was used to examine intervention/other effects on screening for ACTs while accounting for clustering of participants in recruitment chains. Results: Approximately half in the PDI (46.0%) were screened compared to 1.6% among controls. In the mixed model, screening was much more likely in the PDI than control arm (AOR=52.5; z=5.42, p < .0001), and among participants doing more recruiting/educating (AOR=1.39; z=2.63, p < .01). Conclusions: Increasing rates of screening among PLHA from racial/ethnic minority backgrounds is critical to advance science. This intervention was highly efficacious and also can be adapted to other trial, biomedical research, and clinical settings where disparities persist.
Learning Areas:
Planning of health education strategies, interventions, and programsSocial and behavioral sciences Learning Objectives: Keywords: Clinical Trials, Access
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am the study PI. I led the design of the program and oversee the program and research study. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 5163.0: HIV Vaccine and Treatment Issues
|